Several biomarkers have been identified in order to predict the severity of COVID‐19, such as lymphocyte count, neutrophil‐to‐lymphocyte ratio (NLR), C‐reactive protein (CRP), interleukin‐6 (IL‐6), and D‐dimer. This evidence concerns the gene IL6 and COVID-19.